# Centile Bioscience Inc. — Form D

Centile Bioscience Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-16. The offering totals $4.1M, of which $3.1M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2026-04-16
- Form: D
- Accession: 0002129392-26-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.1M
- Amount sold: $3.1M
- Remaining: $1.0M
- Investors: 3
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-580785

## Issuer

- Name: Centile Bioscience Inc.
- CIK: 0002129392
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5023 WISSIOMING RD., BETHESDA, MD, 20816
- Phone: 240-204-0747

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Joshua Bernstock | Related Person | Bethesda, MD |
| Richard Bethlehem | Related Person | Bethesda, MD |
| Hannah Mamuszka | Related Person | Bethesda, MD |
| L. KEITH MULLINS | Related Person | Bethesda, MD |
| Jakob Seidlitz | Related Person | Bethesda, MD |

## More

- [CIK 2129392 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2129392&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002129392-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.